← Leaderboards
Perry Michael Nicassio
University Of California Los Angeles
$1,725,614
Attributed
$1,725,614
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $363.1K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,725,614 · 1
By mechanism
R01$1,725,614 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Helen Lavretsky$17,053,369
- Brennan Spiegel$10,532,609
- Damini Jawaheer$5,323,327
- Anand Kumar$10,906,640
- Julienne E Bower$9,080,735
Others in their field
Top investigators on “Tumor Necrosis Factor Alpha”
- Dan M Cooper · University Of California San Diego$16,544,868
- Steven P Engebretson · Columbia University Health Sciences$11,509,123
- Craig J McClain · University Of Louisville$10,748,767
- John T McDevitt · University Of Maryland Baltimore$10,396,534
- Debra Lynn Laskin · Rutgers Biomedical And Health Sciences$10,232,985
- Cun-Yu Wang · University Of California Los Angeles$9,714,642
Research focus
Tumor Necrosis Factor AlphaInterleukin 6SleepMeditationRheumatoid ArthritisBehavioral /Social Science Research TagInterleukin 1Cognitive Behavior TherapyClinical ResearchAlternative MedicineDepressionArthritis TherapyPatient Oriented ResearchBody Physical ActivityHuman Therapy EvaluationHealth BehaviorHuman SubjectLongitudinal Human StudyStress ManagementCognitive TherapyBaseDesignClinical EfficacyAttention
Grant awards (5)
Behavioral Treatments for Rheumatoid Arthritis$316,793
R01 · FY2007 · AR · contact PI
Behavioral Treatments for Rheumatoid Arthritis$326,254
R01 · FY2006 · AR · contact PI
Behavioral Treatments for Rheumatoid Arthritis$363,075
R01 · FY2005 · AR
Behavioral Treatments for Rheumatoid Arthritis$360,921
R01 · FY2004 · AR
Behavioral Treatments for Rheumatoid Arthritis$358,571
R01 · FY2003 · AR